ロード中...
Randomized, controlled crossover study of IVIg for demyelinating polyneuropathy and diabetes
OBJECTIVE: To determine whether IV immunoglobulin (IVIg) is more effective than placebo at reducing disability in patients with diabetes and demyelinating polyneuropathy features. METHODS: This is a double-blinded, single-center, randomized, controlled crossover trial of IVIg treatment vs placebo. T...
保存先:
| 出版年: | Neurol Neuroimmunol Neuroinflamm |
|---|---|
| 主要な著者: | , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Lippincott Williams & Wilkins
2019
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6943235/ https://ncbi.nlm.nih.gov/pubmed/31454771 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1212/NXI.0000000000000586 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|